BCR::ABL alone fails to confer self-renewal capacity to GMPs; instead, aberrant activation of RUNX1/EVI1 (8), GATA-2 (9), and Msi2 (10) has been implicated in the acute transformation of CML. Here, RUNX1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.